Vascular interventions/innovations and therapeutic advances (vita): car peptide therapeutic adjuvant for PAH targeted therapy
Ended Definitive Contract Awarded Last action
- Contract number
- HHSN268201400006C
- Awardee
-
Vascular Biosciences UEI ETJLM26WRKP5
- Awarding agency
-
National Heart Lung and Blood Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,149,127
Award facts
- Contract value 100% obligated
- $1,149,127.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 31 offers Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Durham, NC 27703, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | $0 | |
| Exercise an Option | $385,534 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $401,635 | |
| Original award | $361,958 |
Quick answers
Who was awarded contract HHSN268201400006C?
HHSN268201400006C was awarded to Vascular Biosciences by National Heart Lung and Blood Institute (National Institutes of Health) on November 15, 2013.
How much is contract HHSN268201400006C worth?
The government has obligated $1,149,127 on HHSN268201400006C.
Was contract HHSN268201400006C competed?
The extent of competition for HHSN268201400006C was full and open competition. The government received 31 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award